U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515781) titled 'VivaStent Feasibility Study' on March 31.
Brief Summary: Subjects are enrolled in the study following signature of the Informed Consent Form and confirmation of eligibility criteria.
During the screening/baseline phase, demographic and clinical data, medical history, concomitant medications, available imaging (contrast-enhanced CTV or MRV), and THI and HIT-6 questionnaires are collected. Pre-procedural medication are initiated one week prior to the procedure, in accordance with standard medical practice.
Subjects are admitted prior to the procedure according to local practice. Required laboratory tests, neurological assessments (m...